ASCO: Disease-Free Survival Prolonged With Exercise Program in Colon Cancer
By Elana Gotkine HealthDay Reporter
TUESDAY, June 3, 2025 -- For patients with resected colon cancer who have completed adjuvant chemotherapy, a three-year structured exercise program results in significantly longer disease-free survival, according to a study published online June 1 in the New England Journal of Medicine to coincide with the annual meeting of the American Society of Clinical Oncology, held from May 31 to June 4 in Chicago.
Kerry S. Courneya, Ph.D., from the University of Alberta in Edmonton, Canada, and colleagues conducted a phase 3 randomized trial at 55 centers involving patients with resected colon cancer who had completed adjuvant chemotherapy to participate in a structured exercise program (exercise group) or to receive health education materials alone (health education group) during a three-year period (445 and 444 patients, respectively).
The researchers found that at a median follow-up of 7.9 years, disease-free survival was significantly longer in the exercise group versus the health education group (hazard ratio for disease recurrence, new primary cancer, or death, 0.72). Five-year disease-free survival was 80.3 and 73.9 percent in the exercise and health education groups, respectively. The results supported longer overall survival in the exercise group versus the health education group (hazard ratio for death, 0.63). Eight-year overall survival was 90.3 and 83.2 percent in the exercise and health education groups, respectively. Compared with the health education group, musculoskeletal adverse events occurred more often in the exercise group (18.5 versus 11.5 percent of patients).
"Our trial provides robust evidence of a substantial benefit-to-harm ratio in favor of structured exercise over a sedentary lifestyle and supports its incorporation into standard care," the authors write. "Knowledge alone, however, is unlikely to change patient behavior and outcomes. To achieve meaningful increases in exercise will require that health systems invest in behavior-support programs."
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-06-04 06:00
Read more

- Combo Diabetes/High Blood Pressure Threatening More American Lives
- Odds of Cardiovascular Events Up for RSV Hospitalization Versus COVID-19 Hospitalization
- Bilateral Salpingo-Oophorectomy Beneficial in BRCA1/2 Carriers With Personal History of Breast Cancer
- Double Lung Transplant Saves Mother Of Twins
- Sweet Tooth Explained: Researchers Reveal How We Taste Sugar
- Adults Diagnosed With Type 1 Diabetes Face Heart Health Issues, Risk Of Early Death
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions